Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

In this week’s edition of InnovationRx, we look at the policy uncertainty around vaccines, sex differences in GLP-1 drug side ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Viking Therapeutics ( VKTX -0.30%) is a promising growth stock with a strong GLP-1 drug candidate in VK2735, which may ...

As part of the new agreement, 8Greens products will begin being sold through Grove Collaborative's marketplace in April and ...

The FDA ordered compounding pharmacies to stop making copycat versions of weight loss drugs like Ozempic and Zepbound now ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

Rafael Acevedo, president of yogurt at Danone North America, discusses why the CPG giant’s focus on protein, gut health and ...

Jim Cramer in a latest program on CNBC commented on The Campbell’s Company (NASDAQ:CPB) earnings and highlighted weak organic sales guidance and volume mix declines. Cramer believes GLP-1 weight loss ...

We recently published a list of 8 Stocks in Focus Under Jim Cramer’s Game Plan. In this article, we are going to take a look ...

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.